Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery

NCT02665533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2016-08-19

No results posted yet for this study

Summary

The main aim of the study is to investigate the pre-emptive effect of dexamethasone and diclofenac associated to codeine to prevent the pain, edema and limited mouth opening at the extraction of third molar.

Conditions

Interventions

DRUG

Dexamethasone

Dexamethasone 8 mg

DRUG

Diclofenac Sodium associated with Codeine

Diclofenac Sodium 50 mg associated with Codeine 50 mg

Sponsors & Collaborators

  • Federal University of the Valleys of Jequitinhonha and Mucuri

    lead OTHER

Principal Investigators

  • Thiago Lima · Federal University of the Valleys of Jequitinhonha and Mucuri

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-01-31
Completion
2016-07-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665533 on ClinicalTrials.gov